Institute MECHNIKOV, created as part of the Russian and Nicaraguan project in Managua, began production of commercial batches of influenza vaccine. April 10. Managua. Institute MECHNIKOV has launched the production of a commercial vaccine batches in Managua (Nicaragua). The launch of the production lines was attended by the advisor for investments of the Government of

The Flu: Stop the Spread

During the vaccination campaign in the Russian Federation, employees of the largest Russian manufacturer of influenza vaccines for adults, St. Petersburg Scientific Research Institute of Vaccines and Serums under Federal Medical Biological Agency of Russia were the first to have the opportunity to get vaccinated with a new influenza vaccine from their own production “Flu-M”. The
Tagged under: ,

Updating knowledge with new impressions

Fifty foreign students from the Saint Petersburg State Chemical Pharmaceutical Academy became familiar with the modern biotechnology of the St. Petersburg Scientific Research Institute of Vaccines and Serums and Biopharmaceutical Plant under Federal Medical Biological Agency of Russia. Our Institute is cooperating successfully with the Saint Petersburg State Chemical Pharmaceutical Academy for several years. On a permanent basis,
Tagged under:
Sep. 6 – 15, under the patronage of President Bashar al-Assad, the 60th edition of Damascus International Fair was held. Among other participants, the Russian delegation was represented by the director of St. Petersburg Scientific Research Institute of Vaccines and Serums Victor Trukhin and the director’s advisor Sergey Arakelov. During the exhibition, Vladimir Uiba, the director of
Tagged under: , ,
In June 2018, as part of the strengthening of potential export, the St. Petersburg Scientific Research Institute of Vaccines and Serums has successfully passed the certification audit for compliance with antigen production quality for influenza vaccines. Food and Drug Administration of the Islamic Republic of Iran issued the certificate in August of this year. It
Director of PAHO Doc. Carissa Etienne visited Institute of vaccines and serums in Saint Petersburg (SPbSRIVS) within the framework of cooperation between Pan American Health Organization and Federal Medico-Biological Agency of Russia (FMBA), which along with other institutions includes SPbSRIVS. Doctor Etienne arrived to Russia to be acquainted with the latest achievements of Russian public
20 million
St. Petersburg Research Institute of Vaccines and Serums will produce more than 20 million doses of preventive flu vaccines. This epidemiological season SPbSRIVS will produce and deliver to Nacimbio (National Immunobiological Company) 20 million doses of preventive flu vaccines following the National calendar of vaccination. “First 6 millions of doses had been already shipped to
cooperation
At the First Cuba-Russia Medico-Pharmaceutical Business Forum in Habana (Cuba) SPbSRIVS and state company BioCubaFarma signed the Memorandum of Understanding. This document became a next step in the development of cooperation between specialists of Saint-Petersburg Institute and their Cuban colleagues. In particular the Memorandum provides joint development of the new Immunobiological medicines, registration of Russian
Tagged under: , , ,
conference

SPbSRIVS took part in IVW 2017

The leading international influenza vaccines conference IVW 2017 is invariably attended by prominent influenza virologists. Mr. John Oxford (founder of influenza vaccinology in the modern sense, pictured), Mr. Peter Palese (expert on universal vaccines), Mr. Ad Osterhaus (expert on prepandemic vaccines against animal flu), Mr. John Wood (expert in biological standardization), Mr. Robert Webster (expert